Case Report

Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We present a case of a 21 year old male patient diagnosed with a 2.2 cm prolactin-secreting adenoma in contact with the optic chiasm. The patient was treated with up to 6mg/week of cabergoline (total cumulative dose 814 mg) and developed mild valvulopathy. Valvulopathy was subsequently reversed after discontinuation of cabergoline therapy.

Original languageEnglish (US)
Article number3062.1
JournalF1000Research
Volume3
DOIs
StatePublished - Jul 25 2014

Fingerprint

Optic Chiasm
Pharmaceutical Preparations
Prolactin
Adenoma
Optics
cabergoline
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{db369b65fa09484bb6b3b0310df70433,
title = "Case Report: Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation",
abstract = "We present a case of a 21 year old male patient diagnosed with a 2.2 cm prolactin-secreting adenoma in contact with the optic chiasm. The patient was treated with up to 6mg/week of cabergoline (total cumulative dose 814 mg) and developed mild valvulopathy. Valvulopathy was subsequently reversed after discontinuation of cabergoline therapy.",
author = "Shirley McCartney and Yedinak, {Christine (Chris)} and Dillard, {Troy H.} and Kevin Wei and Maria Fleseriu",
year = "2014",
month = "7",
day = "25",
doi = "10.12688/f1000research.3062.1",
language = "English (US)",
volume = "3",
journal = "F1000Research",
issn = "2046-1402",
publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - Case Report

T2 - Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation

AU - McCartney, Shirley

AU - Yedinak, Christine (Chris)

AU - Dillard, Troy H.

AU - Wei, Kevin

AU - Fleseriu, Maria

PY - 2014/7/25

Y1 - 2014/7/25

N2 - We present a case of a 21 year old male patient diagnosed with a 2.2 cm prolactin-secreting adenoma in contact with the optic chiasm. The patient was treated with up to 6mg/week of cabergoline (total cumulative dose 814 mg) and developed mild valvulopathy. Valvulopathy was subsequently reversed after discontinuation of cabergoline therapy.

AB - We present a case of a 21 year old male patient diagnosed with a 2.2 cm prolactin-secreting adenoma in contact with the optic chiasm. The patient was treated with up to 6mg/week of cabergoline (total cumulative dose 814 mg) and developed mild valvulopathy. Valvulopathy was subsequently reversed after discontinuation of cabergoline therapy.

UR - http://www.scopus.com/inward/record.url?scp=84915818648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84915818648&partnerID=8YFLogxK

U2 - 10.12688/f1000research.3062.1

DO - 10.12688/f1000research.3062.1

M3 - Article

VL - 3

JO - F1000Research

JF - F1000Research

SN - 2046-1402

M1 - 3062.1

ER -